ECS Botanics: German GMP guidance could have ‘global impact’ by Adam Sheldon July 8, 2026July 8, 2026 New guidance issued by a German pharmaceutical regulator could reshape global supply chains by closing a […]
Austranna says high-tech facility could ‘double’ Australia’s growing capacity by Adam Sheldon June 16, 2026June 18, 2026
‘We could become a formidable force’: Cannaponics launches public capital raise by Adam Sheldon May 13, 2026May 14, 2026
Ora Pharm buys key Helius Therapeutics assets in major NZ deal by Adam Sheldon May 13, 2026May 13, 2026
News in brief: Puro completes first hash export; GrowerIQ renews GMP compliance; MedReleaf inks Leafio deal; Vitura forms advisory group; Althea to become Peak Processing by Adam Sheldon December 2, 2025February 21, 2026
‘Not a revenue grab’: Curaleaf International CEO maps out Australian expansion plan by Adam Sheldon November 27, 2025December 2, 2025
Compliance gaps, slow licensing and strict rules put Australia at risk on global stage, expert warns by Adam Sheldon November 26, 2025November 26, 2025
TGA issues quality warning and prepares to begin testing after reports of ‘questionable’ products by Steve Jones April 19, 2024April 23, 2024
No imported products tested since new GMP rules came into force, TGA admits, as MCIA calls for meeting by Steve Jones February 29, 2024February 29, 2024
